Dianthus Therapeutics, Inc. (NASDAQ:DNTH) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Michael W. Bonney Other companies: Immunic, Inc. (Chair · Since May 16, 2026); Autolus Therapeutics plc (Director · Since at least Mar 18, 2026); Alnylam Pharmaceuticals, Inc. (Director · Since at least Dec 17, 2014); Bristol-Myers Squibb Company (Director · Nov 20, 2019 – Jun 30, 2021 · Past); Kaleido Biosciences, Inc. (Director · Feb 27, 2019 – Jun 30, 2021 · Past); Syros Pharmaceuticals, Inc. (Director · Jun 14, 2018 – Jun 11, 2019 · Past); Sarepta Therapeutics, Inc. (Director · Dec 4, 2017 – Feb 28, 2020 · Past); Global Blood Therapeutics Inc (Director · Feb 8, 2016 – Jun 16, 2016 · Past); Celgene Corporation (Director · Apr 14, 2015 – Nov 20, 2019 · Past); NPS Pharmaceuticals Inc (Director · Jan 17, 2006 – Feb 21, 2015 · Past); Cubist Pharmaceuticals Inc (Chief Executive Officer, Director · Jan 3, 2006 – Jan 21, 2015 · Past) | Director · Jun 20, 2018 – Jun 1, 2021 · Past |
| Peter Harwin Other companies: Damora Therapeutics, Inc. (Chairman of the Board · Since at least Nov 10, 2025); Crescent Biopharma, Inc. (Chair of Board · Since at least Jun 13, 2025); Jade Biosciences, Inc. (Director · Since at least Apr 28, 2025); Zenas BioPharma, Inc. (Director · Since at least Sep 12, 2024); Oruka Therapeutics, Inc. (Director · Since at least Aug 29, 2024); Apogee Therapeutics, Inc. (Director · Since at least Jul 13, 2023); Spyre Therapeutics, Inc. (Director · Since at least Jun 22, 2023); Cogent Biosciences, Inc. (Founding Partner, Fairmount Funds Management LLC · Since at least Jul 6, 2020); Viridian Therapeutics, Inc. (Director · Oct 27, 2020 – Jun 26, 2024 · Past) | Director · Sep 11, 2023 – Jan 22, 2024 · Past |
| Alison Frances Lawton Other companies: ProQR Therapeutics N.V. (Director · Since at least Mar 18, 2026); Spyre Therapeutics, Inc. (Director · Dec 15, 2020 – Jun 22, 2023 · Past); X4 Pharmaceuticals, Inc. (Director · Oct 5, 2020 – Jun 10, 2024 · Past); Kaleido Biosciences, Inc. (See Remarks, Director · Feb 27, 2019 – Apr 15, 2020 · Past); CoLucid Pharmaceuticals Inc (Director · Mar 11, 2016 – Mar 1, 2017 · Past); Tempest Therapeutics, Inc. (Chief Operating Officer · Jan 21, 2013 – Jun 7, 2013 · Past); Verastem, Inc. (Director · Nov 26, 2012 – Jun 21, 2019 · Past); Cubist Pharmaceuticals Inc (Director · Feb 15, 2012 – Jan 21, 2015 · Past) | Director · Since at least Dec 22, 2020 |
| Tomas Kiselak Other companies: Cyclerion Therapeutics, Inc. (Chairman · Since at least Apr 1, 2026); Crescent Biopharma, Inc. (Director · Since at least Jun 13, 2025); Jade Biosciences, Inc. (Director · Since at least Apr 28, 2025); Zenas BioPharma, Inc. (Director · Since at least Sep 12, 2024); Oruka Therapeutics, Inc. (Director · Since at least Aug 29, 2024); Apogee Therapeutics, Inc. (Director · Since at least Jul 13, 2023); Spyre Therapeutics, Inc. (Director · Since at least Jun 22, 2023); Viridian Therapeutics, Inc. (Director · Since at least Oct 27, 2020) | Director · Sep 11, 2023 – Sep 27, 2024 · Past |
| Jonathan Violin Other companies: Cyclerion Therapeutics, Inc. (Chief Executive Officer · Since at least Apr 1, 2026); Crescent Biopharma, Inc. (Director · Since at least Jun 13, 2025); Astria Therapeutics Inc (Director · Since at least Jan 28, 2021); Viridian Therapeutics, Inc. (Chief Executive Officer, Director · Oct 27, 2020 – Feb 2, 2023 · Past); Trevena, Inc. (SVP-Scientific Affairs & IR · Jan 29, 2018 – Feb 28, 2018 · Past) | Director · Since at least Sep 11, 2023 |
| Thomas Daniel Other companies: Gossamer Bio, Inc. (Director · Since at least Feb 7, 2019); Larimar Therapeutics, Inc. (Director · Mar 3, 2016 – May 12, 2021 · Past); Juno Therapeutics Inc (Director · Aug 11, 2015 – Mar 5, 2018 · Past); Epizyme Inc (Director · May 30, 2013 – May 30, 2013 · Past); Celgene Corporation (see remarks · Feb 15, 2012 – Dec 31, 2015 · Past) | Director · Jun 20, 2018 – Jun 28, 2022 · Past |
| Bruce Booth Other companies: Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Vigil Neuroscience Inc (Director · Since at least Jan 6, 2022); Kymera Therapeutics, Inc. (Director · Since at least Mar 12, 2021); Tectonic Therapeutic, Inc. (Director · Jun 10, 2021 – Jun 6, 2023 · Past) | Director · Jun 1, 2021 – Jun 28, 2022 · Past |
| Leon O Moulder Jr Other companies: Zenas BioPharma, Inc. (See Remarks, Director · Since at least Sep 12, 2024); Zai Lab Ltd. (Director · Since at least Jan 1, 2021); Trevena, Inc. (Director · May 16, 2018 – Jun 15, 2023 · Past); Tesaro Inc (Chief Executive Officer, Director · Mar 1, 2018 – Jan 22, 2019 · Past) | Director · Sep 11, 2023 – May 23, 2024 · Past |
| Michael Vasconcelles Other companies: Day One Biopharmaceuticals Inc (Head of Research and Dev. · Since at least Jun 16, 2025); Kura Oncology, Inc. (Director · Since at least Sep 13, 2024); ImmunoGen Inc (EVP R&D & MEDICAL AFFAIRS · Dec 29, 2022 – Feb 12, 2024 · Past); Cogent Biosciences, Inc. (Chief Medical Officer · Mar 28, 2018 – Mar 1, 2019 · Past) | Director · Aug 15, 2022 – Aug 15, 2022 · Past |
| David Scadden Other companies: Editas Medicine, Inc. (Director · Since at least Feb 5, 2019); Agios Pharmaceuticals, Inc. (Independent Director · Since at least May 27, 2017); Carisma Therapeutics, Inc. (Director · Jun 30, 2024 – Jul 1, 2024 · Past) | Director · Jun 20, 2018 – Jun 28, 2022 · Past |
| Jason Ryan Other companies: GeneDx Holdings Corp. (Director · Since at least Jul 22, 2021); Singular Genomics Systems Inc (Director · May 26, 2021 – Feb 21, 2025 · Past); Foundation Medicine Inc (Chief Financial Officer · Sep 24, 2013 – Jul 31, 2018 · Past) | See Remarks · Jan 1, 2019 – Feb 10, 2020 · Past |
| Jeffrey Albers Other companies: Spyre Therapeutics, Inc. (Director · Since at least Nov 22, 2023); Kymera Therapeutics, Inc. (Director · Since at least Aug 20, 2020); Blueprint Medicines Corp (Director · Since at least Apr 30, 2015) | Director · Jun 20, 2018 – Jun 28, 2022 · Past |
| Jeffrey Humphrey Other companies: Lantheus Holdings, Inc. (Chief Medical Officer · May 28, 2024 – Jun 17, 2024 · Past); Cyteir Therapeutics Inc (Director · Dec 15, 2021 – Feb 3, 2023 · Past); Constellation Pharmaceuticals Inc (Chief Medical Officer · Jun 22, 2020 – Jul 15, 2021 · Past) | Chief Medical Officer · Oct 1, 2021 – Aug 1, 2022 · Past |
| Adam Veness Other companies: Cyteir Therapeutics Inc (General Counsel · Apr 25, 2022 – Feb 3, 2023 · Past); Acceleron Pharma Inc (SVP, General Counsel and Sec. · Jan 4, 2021 – Nov 19, 2021 · Past) | General Counsel · Since at least Sep 11, 2023 |
| Marino Garcia Other companies: AgomAb Therapeutics NV (Director · Since at least Sep 11, 2026); Synergy Pharmaceuticals Inc (EVP and Chief Strategy Officer · Jan 5, 2018 – Jan 5, 2018 · Past) | President & Chief Executive Officer, Board Member · Since at least Sep 11, 2023 |
| Stephen F Mahoney Other companies: Viridian Therapeutics, Inc. (President and CEO, Director · Since at least Oct 30, 2023); Kiniksa Pharmaceuticals International, plc (President & COO · May 23, 2018 – Sep 17, 2019 · Past) | See Remarks · Nov 2, 2020 – Nov 30, 2022 · Past |
| Steven J Romano Other companies: Silence Therapeutics PLC (EVP and Chief R&D Officer · Since at least Jan 2, 2025); Mallinckrodt Inc (EVP & Chief Sci. Ofcr · Jun 16, 2022 – Jun 16, 2022 · Past) | Director · Since at least Sep 16, 2024 |
| Sujay Kango Other companies: Lite Strategy, Inc. (Director · Nov 22, 2021 – Sep 29, 2023 · Past); Acceleron Pharma Inc (EVP, Chief Commercial Officer · Feb 12, 2018 – Nov 19, 2021 · Past) | Director · Since at least Mar 4, 2025 |
| Thomas W Beetham Other companies: Viridian Therapeutics, Inc. (Chief Operating Officer · Since at least Oct 30, 2023); Kiniksa Pharmaceuticals International, plc (EVP & Chief Legal Officer · May 23, 2018 – Mar 20, 2021 · Past) | See Remarks · Jun 14, 2021 – Nov 30, 2022 · Past |
| Amy Ronneberg Other companies: Actuate Therapeutics, Inc. (Director · Since at least Aug 12, 2024) | Director · Jun 20, 2018 – Jun 28, 2022 · Past |
| Anne McGeorge Other companies: The Oncology Institute, Inc. (Director · Since at least Nov 12, 2021) | Director · Since at least Jun 20, 2019 |
| Cindy Driscoll Other companies: Climb Bio, Inc. (Senior Vice President, Finance · Since at least Jun 17, 2025) | See Remarks · Jun 20, 2018 – Oct 1, 2020 · Past |
| Edward Carr Other companies: Abeona Therapeutics Inc. (Chief Financial Officer · Nov 9, 2018 – Oct 8, 2021 · Past) | Chief Accounting Officer · Since at least Sep 11, 2023 |
| Paula Soteropoulos Other companies: Rallybio Corporation (Lead Independent Director · Since at least May 13, 2025) | Director · Since at least May 22, 2025 |
| Zoran Zdraveski Other companies: TScan Therapeutics, Inc. (Chief Legal and Strategy Officer and Secretary · Since at least Sep 7, 2021) | See Remarks · Jun 20, 2018 – Feb 11, 2021 · Past |
| David Roy Witzke | Director · Jan 22, 2024 – Jan 22, 2024 · Past |
| David Wayne Nichols | Chief Technical Officer · May 17, 2022 – Aug 1, 2022 · Past |
| Jason Gardner | See Remarks, Director · Jun 20, 2018 – Nov 30, 2022 · Past |
| Jennifer Davis Ruff | Head of Investor Relations and Corporate Affairs · Since at least Nov 4, 2026 |
| John C Davis Jr | See Remarks · Jun 20, 2018 – Feb 11, 2021 · Past |
| Lisa Olson | See Remarks · Sep 14, 2020 – Aug 1, 2022 · Past |
| Michael David Gregory | Director · Jan 22, 2024 – Jan 22, 2024 · Past |
| Michael P Cooke | Chief Scientific Officer · Jun 20, 2018 – Dec 2, 2019 · Past |
| Ryan Savitz | Executive Vice President, Chief Financial Officer & Chief Business Officer · Since at least Sep 11, 2023 |
| Simon Read | Director · Since at least May 22, 2025 |
| Simrat Randhawa | Executive Vice President, Head of R&D · Since at least Sep 11, 2023 |